{
    "clinical_study": {
        "@rank": "144801", 
        "arm_group": [
            {
                "arm_group_label": "Narrow pulse", 
                "arm_group_type": "Experimental", 
                "description": "Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms."
            }, 
            {
                "arm_group_label": "Wide pulse", 
                "arm_group_type": "Experimental", 
                "description": "Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the capacity of a 6-week treatment with\n      neuromuscular electrical stimulation to improve walking in individuals whose mobility has\n      been compromised by multiple sclerosis."
        }, 
        "brief_title": "Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Participants will be randomly assigned to one of two study arms.  Those in one arm will\n      receive a treatment with narrow stimulus pulses (0.4 ms) and those in the other arm will\n      receive wide stimulus pulses (1 ms).  The electrical stimulation will be delivered with a\n      Vectra Genisys System."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Able to read, understand, and speak English to ensure safe participation in the\n             project\n\n          -  Difficulties with walking\n\n          -  On stable doses of Ampyra, provigil, or other symptomatic-treating medications\n\n          -  No systemic steroids within the last 30 days\n\n          -  Not currently exercising more than 2x/wk\n\n          -  Able to arrange own transportation to and from the laboratories\n\n          -  Provide informed consent, including willingness to be randomly assigned to one of the\n             two groups\n\n        Exclusion Criteria:\n\n          -  Documented MS-related relapse in the last 3 months\n\n          -  Medical diagnosis or condition that is considered to be an absolute or relative\n             contraindication to participating in exercise training, such as major renal,\n             pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer (other than treated basal\n             cell cancer), other neurological disorders, or pregnancy\n\n          -  Poorly controlled diabetes mellitus or hypertension\n\n          -  History of seizure disorders\n\n          -  Alcohol dependence or abuse (\u22652 drinks/day), or present history (last 6 months) of\n             drug abuse\n\n          -  Inability to attend exercise sessions 3 days per week for 6 weeks"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02152085", 
            "org_study_id": "13-0720", 
            "secondary_id": "R03HD079508"
        }, 
        "intervention": [
            {
                "arm_group_label": "Narrow pulse", 
                "description": "Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.", 
                "intervention_name": "Narrow pulse", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Wide pulse", 
                "description": "Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.", 
                "intervention_name": "Wide pulse", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Walking", 
            "Mobility", 
            "Neuromuscular electrical stimulation", 
            "Multiple sclerosis"
        ], 
        "lastchanged_date": "June 3, 2014", 
        "location": {
            "contact": {
                "email": "jeffrey.hebert@ucdenver.edu", 
                "last_name": "Jeffrey R Hebert, PhD, PT", 
                "phone": "303-724-9595"
            }, 
            "facility": {
                "address": {
                    "city": "Boulder", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80309"
                }, 
                "name": "University of Colorado"
            }, 
            "investigator": {
                "last_name": "Roger M Enoka, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis", 
        "overall_contact": {
            "email": "jeffrey.hebert@ucdenver.edu", 
            "last_name": "Jeffrey R Hebert, PhD, PT", 
            "phone": "303-724-9595"
        }, 
        "overall_contact_backup": {
            "email": "enoka@colorado.edu", 
            "last_name": "Roger Enoka, PhD", 
            "phone": "303-492-4965"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Colorado, Boulder", 
                "last_name": "Roger Enoka, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Colorado Anschutz", 
                "last_name": "Jeffrey Hebert, PhD, PT", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Distance walked in 6 min", 
            "safety_issue": "No", 
            "time_frame": "Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week)."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02152085"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The time it takes to walk 25 ft", 
                "measure": "Maximal walking speed", 
                "safety_issue": "No", 
                "time_frame": "Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week)."
            }, 
            {
                "description": "The peak force that can be produced by thigh (knee extensor) and calf (plantarflexor) muscles", 
                "measure": "Muscle strength", 
                "safety_issue": "No", 
                "time_frame": "Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week)."
            }, 
            {
                "description": "Amount of physical activity as measured with accelerometers attached to the ankle", 
                "measure": "Daily levels of physical activity", 
                "safety_issue": "No", 
                "time_frame": "Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week)."
            }
        ], 
        "source": "University of Colorado, Boulder", 
        "sponsors": {
            "collaborator": {
                "agency": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Colorado, Boulder", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}